灵康药业集团股份有限公司

Core Viewpoint - The company, Lingkang Pharmaceutical Group Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented, and confirming that there are no false records or significant omissions [2][3]. Financial Data Summary - The financial statements for the third quarter are unaudited, indicating that the financial data may not have undergone a formal audit process [3][7]. - The company reported a total of 17,701,793 circulating shares held in its repurchase account, representing 2.45% of the total shares [6]. Shareholder Information - The report includes details on the total number of ordinary shareholders and the status of major shareholders, although specific figures for the top ten shareholders are not provided [5]. Other Important Information - There are no additional reminders or significant operational updates regarding the company's performance during the reporting period [6].